Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device

NCT04702529 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-12-24

No results posted yet for this study

Summary

A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars

Conditions

  • Scars, Hypertrophic

Interventions

DEVICE

Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device)

Administration of 3 Rapid Acoustic Pulse (RAP) treatments

Sponsors & Collaborators

  • United States Naval Medical Center, San Diego

    collaborator FED
  • Soliton

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-22
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702529 on ClinicalTrials.gov